Immunohistochemical analysis revealed the expression of CD59, CD55, and CD46 on uveal melanoma (101), thyroid carcinoma (102), lung and kidney cancer (103, 104), colon adenocarcinoma (105), and prostate cancer (106). The gene discussed is CD59; the disease is prostate cancer.